Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual-acting glucokinase activator

Miao, J; Fu, P; Ren, S; Hu, C; Wang, Y; Jiao, CF; Li, P; Zhao, Y; Tang, C; Qian, YL; Yang, R; Dong, YL; Rong, J; Wang, YH; Jin, XW; Sun, Y; Chen, L

Chen, L (通讯作者)，Hua Med Shanghai Ltd, 275 Aidisheng Rd, Shanghai 201203, Peoples R China.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022; 15 (2): 548

Abstract

Dorzagliatin is a novel allosteric glucokinase activator targeting both pancreatic and hepatic glucokinase currently under clinical investigation for ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索